User menu

Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological study.

Bibliographic reference Denis, Marie Armelle ; Cosyns, Jean-Pierre ; Persu, Alexandre ; Dewit, Olivier ; de Galocsy, Chantal ; et. al. Control of AA amyloidosis complicating Crohn's disease: a clinico-pathological study.. In: European Journal of Clinical Investigation, Vol. 43, no.3, p. 292-301 (2013)
Permanent URL http://hdl.handle.net/2078.1/136292
  1. Cohen, Gastroenterology, 12, 502 (1949)
  2. GREENSTEIN ADRIAN J., SACHAR DAVID B., NANNAN PANDAY ADITYA K., DIKMAN STEVEN H., MEYERS SAMUEL, HEIMANN TOMAS, GUMASTE VIVEK, WERTHER J. LAWRENCE, JANOWITZ HENRY D., Amyloidosis and Inflammatory Bowel Disease A 50-Year Experience with 25 Patients : , 10.1097/00005792-199209000-00001
  3. Glenner George G., Amyloid Deposits and Amyloidosis : The β-Fibrilloses(First of Two Parts), 10.1056/nejm198006053022305
  4. Merlini Giampaolo, Bellotti Vittorio, Molecular Mechanisms of Amyloidosis, 10.1056/nejmra023144
  5. Waldenström, Acta chir Scandinav, 63, 479 (1928)
  6. Lachmann Helen J., Goodman Hugh J.B., Gilbertson Janet A., Gallimore J. Ruth, Sabin Caroline A., Gillmore Julian D., Hawkins Philip N., Natural History and Outcome in Systemic AA Amyloidosis, 10.1056/nejmoa070265
  7. Satsangi J, The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications, 10.1136/gut.2005.082909
  8. Levey Andrew S., A More Accurate Method To Estimate Glomerular Filtration Rate from Serum Creatinine: A New Prediction Equation, 10.7326/0003-4819-130-6-199903160-00002
  9. Morel-Maroger, Adv Nephrol Necker Hosp, 6, 79 (1976)
  10. Saverymuttu S H, Hodgson H J, Chadwick V S, Pepys M B, Differing acute phase responses in Crohn's disease and ulcerative colitis., 10.1136/gut.27.7.809
  11. De Beer F.C, Fagan ElizabethA, Hughes G.R.V, Mallya R.K, Lanham J.G, Pepys M.B, SERUM AMYLOID-A PROTEIN CONCENTRATION IN INFLAMMATORY DISEASES AND ITS RELATIONSHIP TO THE INCIDENCE OF REACTIVE SYSTEMIC AMYLOIDOSIS, 10.1016/s0140-6736(82)90321-x
  12. Freeman Hugh J, Application of the Montreal Classification for Crohn’s Disease to a Single Clinician Database of 1015 Patients, 10.1155/2007/951526
  13. Verbanck J., Lameire N., Praet M., Ringoir S., Elevvaut A., Barbier F., Renal Amyloidosis As Complication Of Crohn’s Disease, 10.1080/22953337.1979.11718660
  14. Gries, Med Klin, 84, 65 (1989)
  15. Tovbin, Clin Nephr, 53, 147 (2000)
  16. Larvol, Gastroenterol Clin Biol, 22, 639 (1998)
  17. Mandelstam Paul, Simmons Donald E., Mitchell Bonnie, Regression of Amyloid in Crohnʼs Disease after Bowel Resection A 19-Year Follow-up : , 10.1097/00004836-198906000-00016
  18. Leiper K, Howse MLP, Bell GM, Resolution of nephrotic syndrome caused by amyloidosis following surgery for Crohn's disease, 10.12968/hosp.2000.61.11.1469
  19. Elkayam Ori, Hawkins Philip N., Lachmann Helen, Yaron Michael, Caspi Dan, Rapid and complete resolution of proteinuria due to renal amyloidosis in a patient with rheumatoid arthritis treated with infliximab, 10.1002/art.10581
  20. Fernández-Nebro Antonio, Tomero Eva, Ortiz-Santamaría Vera, Castro María Carmen, Olivé Alejandro, de Haro Manuel, García-Vicuña Rosa, González-Mari María Victoria, Laffón Armando, García-Vicuña Rosario, Treatment of rheumatic inflammatory disease in 25 patients with secondary amyloidosis using tumor necrosis factor alpha antagonists, 10.1016/j.amjmed.2005.01.028
  21. Bosca M M, Secondary amyloidosis in Crohn's disease: treatment with tumour necrosis factor inhibitor, 10.1136/gut.2005.082057
  22. Iizuka M, Infliximab as a treatment for systemic amyloidosis associated with Crohn's disease, 10.1136/gut.2005.087577
  23. Park Yoon Kyung, Han Dong Soo, Eun Chang Soo, Systemic amyloidosis with Crohnʼs disease treated with infliximab : , 10.1002/ibd.20289
  24. Verschueren P, Benefit of anti-TNFalpha treatment for nephrotic syndrome in a patient with juvenile inflammatory bowel disease associated spondyloarthropathy complicated with amyloidosis and glomerulonephritis, 10.1136/ard.62.4.368
  25. Appau Kweku A., Fazio Victor W., Shen Bo, Church James M., Lashner Bret, Remzi Feza, Brzezinski Aaron, Strong Scott A., Hammel Jeffrey, Kiran Ravi P., Use of Infliximab within 3 Months of Ileocolonic Resection is Associated with Adverse Postoperative Outcomes in Crohn’s Patients, 10.1007/s11605-008-0646-0
  26. Regueiro Miguel, Schraut Wolfgang, Baidoo Leonard, Kip Kevin E., Sepulveda Antonia R., Pesci Marilyn, Harrison Janet, Plevy Scott E., Infliximab Prevents Crohn's Disease Recurrence After Ileal Resection, 10.1053/j.gastro.2008.10.051
  27. Zemer Deborah, Pras Mordechai, Sohar Ezra, Modan Michaela, Cabili Shaltiel, Gafni Joseph, Colchicine in the Prevention and Treatment of the Amyloidosis of Familial Mediterranean Fever, 10.1056/nejm198604173141601
  28. Livneh, Baillieres, 14, 477 (2000)
  29. Garrido Serrano A., Guerrero Igea F.J., Hierro Guilmain C., Ruiz Lupiañez E., Palomo Gilá S., Respuesta favorable a la colchicina en la amiloidosis secundaria a la enfermedad inflamatoria intestinal, 10.1016/s0210-5705(01)70148-3
  30. Bodin Karl, Ellmerich Stephan, Kahan Melvyn C., Tennent Glenys A., Loesch Andrzej, Gilbertson Janet A., Hutchinson Winston L., Mangione Palma P., Gallimore J. Ruth, Millar David J., Minogue Shane, Dhillon Amar P., Taylor Graham W., Bradwell Arthur R., Petrie Aviva, Gillmore Julian D., Bellotti Vittorio, Botto Marina, Hawkins Philip N., Pepys Mark B., Antibodies to human serum amyloid P component eliminate visceral amyloid deposits, 10.1038/nature09494
  31. Lovat LB, Madhoo S, Pepys MB, Hawkins PN, Long-term survival in systemic amyloid A amyloidosis complicating Crohn's disease, 10.1016/s0016-5085(97)70150-1
  32. Maury C. P. J., Comparative Study of Serum Amyloid A Protein and C-Reactive Protein in Disease, 10.1042/cs0680233
  33. Sack, Mol Biol Med, 5, 61 (1988)
  34. Obici Laura, Raimondi Sara, Lavatelli Francesca, Bellotti Vittorio, Merlini Giampaolo, Susceptibility to AA amyloidosis in rheumatic diseases: A critical overview, 10.1002/art.24735